Slideshows Images Quizzes

Livostin

Last reviewed on RxList: 6/20/2017
Discontinued Warning IconPlease Note: This Brand Name drug is no longer available in the US.
(Generic versions may still be available.)

Livostin Side Effects Center

Last reviewed on RxList 6/20/2017

Livostin (levocabastine hydrochloride) is an antihistamine eye drop used to treat symptoms of eye allergies, such as inflammation, itching, watering, and burning. Livostin is no longer available in the U.S., but generic versions may be available. Common side effects of Livostin include burning, stinging, itching, or watering of the eyes, eye irritation or discomfort, blurred vision, dry or puffy eyes, headache, nosebleed, nausea, or fatigue.

The recommended dosage of Livostin is 1 drop into affected eye(s), as directed by your doctor. Livostin contains a preservative (benzalkonium chloride), so do not wear contact lenses during treatment. Livostin may interact with other eye drops. Tell your doctor all medications and supplements you take. Livostin should be used during pregnancy only if clearly needed. Livostin passes into breast milk. Consult your doctor before breastfeeding.

Our Livostin (levocabastine hydrochloride) Side Effects Center provides a comprehensive view of available drug information on the potential side effects when taking this medication.

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

Livostin Consumer Information
SIDE EFFECTS: Consult your pharmacist.

In the US -

Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

In Canada - Call your doctor for medical advice about side effects. You may report side effects to Health Canada at 1-866-234-2345.

Read the entire patient information overview for Livostin (Levocabastine)

Livostin Professional Information

SIDE EFFECTS

The most frequent adverse experiences reported with the use of LIVOSTIN™ 0.05% (levocabastine hydrochloride ophthalmic suspension) were mild, transient stinging and burning (29%) and headache (5%).

Other adverse experiences reported in approximately 1-3% of patients treated with LIVOSTIN™ were visual disturbances, dry mouth, fatigue, pharyngitis, eye pain/dryness, somnolence, red eyes, lacrimation/discharge, cough, nausea, rash/erythema, eyelid edema, and dyspnea.

Read the entire FDA prescribing information for Livostin (Levocabastine)

Related Resources for Livostin

Related Health

Related Drugs

Read the Livostin User Reviews »

© Livostin Patient Information is supplied by Cerner Multum, Inc. and Livostin Consumer information is supplied by First Databank, Inc., used under license and subject to their respective copyrights.

Health Solutions From Our Sponsors